Digi-LIMS gives pharma QC labs the batch records, stability data, CoA and audit trails DRAP inspectors expect, generated automatically as the lab runs.

Pharmaceutical QC and R&D labs in Pakistan and the GCC live and die by data integrity. A single missing audit trail, an uncontrolled document or a manual transcription error can hold up batch release or trigger a DRAP or SFDA observation. Digi-LIMS is a pharmaceutical LIMS that records every action automatically, so the evidence an inspector asks for already exists before they walk in.
It needs GMP-aligned electronic batch records, Certificate of Analysis generation with digital signatures and version control, stability-study scheduling with pull-points and trend reporting, and full 21 CFR Part 11 audit trails and e-signatures. Digi-LIMS ships with all of these pre-configured, plus out-of-specification and out-of-trend investigation workflows with CAPA and deviation tracking, and direct integration with HPLC, GC and balances so results are captured without re-keying.
Very few DRAP or GMP observations are about a lab getting the science wrong. Overwhelmingly they are about data integrity and traceability: results recorded on loose sheets and transcribed later, uncontrolled spreadsheet versions, missing or back-dated signatures, no clear link between a reported result and the raw instrument data, and analysts sharing a single login. Inspectors summarise this expectation as ALCOA+, that every record be Attributable, Legible, Contemporaneous, Original, Accurate, and also Complete, Consistent, Enduring and Available.
Paper and spreadsheets fail ALCOA+ by design. A shared Excel file has no reliable audit trail, no enforced sign-off, and no way to prove a value was not changed after the fact. When a laboratory runs on Digi-LIMS, every action, who did it, what changed, when, and why, is captured automatically. The evidence an inspector asks for is not assembled the week before an audit; it already exists as a by-product of normal work.
Many products sold to Pakistani labs are billing tools with a sample list bolted on. A genuine pharmaceutical LIMS carries the full weight of a regulated QC workflow.
Results are checked automatically against the registered specification for that product and stage, so pass or fail is a system decision, not an analyst's judgement. An out-of-specification (OOS) or out-of-trend (OOT) result holds the batch and opens a controlled investigation through laboratory phase, root cause and CAPA, every step time-stamped and signed. This is where inspectors probe hardest, because a mishandled OOS is a patient-safety risk.
Stability is where paper quietly collapses: one study can run for years with dozens of pull-points across multiple conditions. Digi-LIMS schedules every pull-point, alerts before it is due, captures results against the protocol, and produces trend and shelf-life reports on demand, ready for a registration dossier or an inspector.
Before release, a batch's full test record is reviewed against its specification in one place. The Certificate of Analysis is then generated directly from the underlying data with electronic signatures and version control, so the CoA can never drift from the results behind it. Review-by-exception surfaces only the results needing a decision, cutting release time without cutting rigour.
HPLC, UHPLC, GC-MS, ICP-OES, FTIR, dissolution units, balances and titrators connect over API or validated file transfer, so results move from instrument to record without re-keying. That removes a whole category of error and preserves the link between the reported result and its raw data, central to any data-integrity review.
Digi-LIMS is configured for the common core these frameworks share: GMP-ready batch records, 21 CFR Part 11 controls (individual logins, an uneditable audit trail, bound electronic signatures), ALCOA+ data integrity enforced by the system, controlled specifications, and full traceability from result to raw data. An honest note: no software is "DRAP certified", and any vendor claiming so is overselling. A LIMS gives you the technical controls that make compliance demonstrable; your procedures, training and validation do the rest, and we support you through them.
A regulated lab cannot simply switch software on; it must be validated. We implement in defined phases from our Lahore team, with validation documentation aligned to GAMP 5 including IQ, OQ and PQ support, so your quality unit has the evidence pack it needs. Most single-site pharma labs go live in six to ten weeks; we tell you honestly if yours is a longer, multi-site case before you commit.
GMP-aligned electronic batch records and review.
Scheduling, pull-points and trend reporting.
Auto CoA with digital signatures and versioning.
Full audit trails and e-signatures.
Investigations, CAPA and deviation tracking.
HPLC/GC and balances via API, no manual entry.
Yes, it provides GMP batch records, CoA with digital signatures, stability documentation and 21 CFR Part 11 audit trails used during DRAP inspections.
Yes, schedule pull-points, record conditions and auto-generate stability trend reports.
Yes, out-of-spec/out-of-trend results trigger controlled investigations with CAPA and deviation tracking.
Yes, the same platform configures for SFDA requirements for pharma labs in Saudi Arabia and the wider GCC.
We'll tailor the walkthrough to your workflows and the standards you report against.
The 20-point checklist our team uses to get pharmaceutical, food and calibration labs audit-ready. Enter your email and we will send it over.
No spam. We connect this form to your mailing tool on launch.